Non-typhoidal
Using laboratory-based surveillance system for
A total of 1,826
Resistance to at least one antimicrobial was found in 72% (1321/1,826) of the isolates. Resistance to at least three antimicrobials was found in 46% (850/1,826) of the isolates. Resistance to all 12 antimicrobials screened was observed in 8 isolates (0.44%, 8/1,826). The resistant prevalence to quinolones including nalidixic acid and ciprofloxacin was 61.9% (1131/1826), of which ciprofloxacin resistance rate was 8.05% (147/1826). The prevalence resistance to all three cephalosporin antimicrobials (cefepime, cefotaxime, and caftazidime) in <5 yr age group was accounted for 90% (89/99).
Additional data and more refined methods can improve future surveillance. The invasive Salmonella isolates should also be included to the antibiotic resistance surveillance for clinical care or public health.
Foodborne disease is a global public health problem. Non-typhoidal
Currently, the national notifiable infectious diseases reporting system required diarrhea case reporting based on symptoms only. Laboratory-based surveillance is not commonly conducted at this time in China [
The surveillance case definition was defined as a person who presented with three or more loose stools within 24 hours and whose diarrhea was associated with one or more of the following symptoms:fever, vomiting, or abdominal pain. Data from September 2009 to December 2012 collected from 28 hospitals in 11 prefectures in Guangdong Province were included in this analysis. Among the 28 hospitals, five were pediatric facilities and the remaining were general hospitals. Epidemiologic information about the patients such as sex, age and consult date were recorded. Spring was defined from March to May, summer from June to August, autumn from September to November, winter from December to February. A standardized protocol was distributed to the sentinel hospitals to guide the collection and processing of stool samples. Clinical laboratories were responsible for
The research involving human subjects have been approved with Guangdong medical ethics comply with the Helsinki Declaration. All the participants have approved the study.
NTS isolates were confirmed using API 20E test strips (bioMerieux, Marcy L’Etoile, France) before serotyping. O and H antigens were characterized using commercial antiserum (S&A Reagents Lab, Bangkok, Thailand) and the serotypes were identified according to Kauffmann-White Scheme [
The antimicrobial susceptibility of the isolates was determined according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI) [
Data were analyzed using SPSS version 13.0 (SPSS Institute, city, state, USA). Chi-squared analysis was performed to test the statistical association between serotypes and age distribution, and to compare the percentage of multi-drug resistant isolates in a given serotype. A
Stool samples were collected from 40,572 patients with diarrhea in Guangdong Province between September 2009 and December 2012, and1,826 NTS isolates were recovered. The isolation rate of NTS was 4.5%. A total of 108 serotypes were identified among the isolates. Ten serotypes accounted for 80% (1,462/1,826) of the NTS isolates in this study, including
The isolation rate in spring was 3.5% (261/7,488), 6.4% (680/10594) in summer, 5.4% (708/13,039) in autumn and 1.9% (177/9,451) in winter. The isolation rate was highest in September 2011 (10%, 83/817) and lowest in December, 2009 (0.8%, 7/861). Infections occurring in autumn accounted for 39% of all NTS cases followed by 37% in summer.
There were 1,031 males and 725 females infected with NTS; the sex of 70 cases was unknown. The overall male/female ratio was 1.4:1. The patients ranged in age from 20 days to 96 years (115 cases unknown). The median age was 1 year. Children <5 years accounted for73% (1,329/1,826) of NTS cases. Of the 1,329 patients,1,084 were infants <1 year. Among infants,
Season Spring 100 (38) 35 (13) 41 (16) 23 (8.8) 6 (2.3) 4 (1.5) 7 (2.7) 0 (0.0) 6 (2.3) 1 (0.4) 2 (0.8) 36 (14) 261 (100) Summer 184 (27) 111 (16) 88 (13) 59 (8.7) 23 (3.4) 23 (3.4) 10 (1.5) 10 (1.5) 5 (0.7) 10 (1.5) 12 (1.8) 145 (21) 680 (100) Autumn 213 (30) 87 (12) 88 (12) 96 (14) 14 (2.0) 13 (1.8) 14 (2.0) 18 (2.5) 11 (1.6) 9 (1.3) 5 (0.7) 140 (20) 708 (100) Winter 53 (30) 21 (12) 28 (16) 11 (6.2) 5 (2.8) 3 (1.7) 7 (4.0) 1 (0.6) 4 (2.3) 0 (0.0) 1 (0.6) 43 (24) 117 (100) Sex Male 324 (31) 151 (15) 125 (12) 102 (10) 27 (2.6) 24 (2.3) 25 (2.4) 16 (1.6) 15 (1.5) 8 (0.8) 12 (1.2) 202 (20) 1031 (100) Female 200 (28) 98 (14) 109 (15) 81 (11) 20 (2.8) 16 (2.2) 12 (1.7) 11 (1.5) 8 (1.1) 12 (1.7) 8 (1.1) 150 (21) 725 (100) Unknown 26 (37) 5 (7.1) 11 (16) 6 (8.6) 1 (1.4) 3 (4.3) 1 (1.4) 2 (2.9) 3 (4.3) 0 (0.0) 0 (0.0) 12 (17) 70 (100) Age ≤1 404 (37) 189 (17) 74 (6.8) 120 (11) 24 (2.2) 26 (2.4) 13 (1.2) 18 (1.7) 13 (1.2) 10 (0.9) 10 (0.9) 183 (17) 1084 (100) ~2 41 (21) 32 (17) 34 (18) 35 (18) 5 (2.6) 2 (1.0) 0 (0.0) 2 (1.0) 5 (2.6) 3 (1.6) 4 (2.1) 29 (15) 192 (100) ~3 24 (28) 10 (9.1) 24 (22) 7 (6.4) 4 (3.6) 1 (0.9) 7 (6.4) 3 (2.7) 1 (0.9) 0 (0.0) 2 (1.8) 27 (24) 110 (100) ~4) 12 (17) 3 (4.3) 22 (32) 6 (8.7) 1 (1.4) 1 (1.4) 4 (5.8) 0 (0.0) 2 (2.9) 3 (4.3) 1 (1.4) 14 (20) 69 (100) ~5 9 (19) 4 (8.5) 18 (38) 2 (4.3) 1 (2.1) 0 (0.0) 1 (2.1) 1 (2.1) 0 (0.0) 1 (2.1) 0 (0.0) 10 (21) 47 (100) ≥5 20 (9.6) 7 (3.3) 54 (26) 11 (5.3) 10 (4.8) 9 (4.3) 12 (5.7) 3 (1.4) 2 (1.0) 3 (1.4) 3 (1.4) 75 (36) 209 (100) Unknown 40 (35) 9 (7.8) 19 (16) 8 (7.0) 3 (2.6) 4 (3.5) 1 (0.9) 2 (1.7) 3 (2.6) 0 (0.0) 0 (0.0) 26 (23) 115 (100) Overall 550 (30) 254 (14) 245 (13) 189 (10) 48 (2.6) 43 (2.4) 38 (2.1) 29 (1.6) 26 (1.4) 20 (1.1) 20 (1.1) 364 (20) 1826 (100)
A total of 168 (9.2%) of the 1,826 NTS isolates were susceptible to all 12 antimicrobials (9.2%).
*Resistance to ampicillin, chloramphenicol, streptomycin, sulfamethoxazole, tetracycline.
Aminoglycosides Getamicin 302 (66) 32 (65) 131 (57) 10 (71) 14 (12) 13 (12) 11 (6.9) 1 (4.8) 8 (27) 6 (40) 3 (11) 3 (27) Streptomycin 335 (73) 36 (74) 154 (67) 9 (64) 44 (36) 41 (39) 22 (14) 1 (4.8) 10 (33) 7 (47) 13 (46) 6 (54) Cephalosporins Cefepime 71 (15) 3 (6.1) 29 (13) 1 (7.1) 14 (12) 6 (5.7) 9 (5.6) 0 (0.0) 3 (10) 0 (0.0) 5 (18) 0 (0.0) Cefotaxime 67 (14) 5 (10) 30 (13) 0 (0.0) 12 (10) 5 (4.8) 10 (6.3) 1 (4.8) 3 (10) 0 (0.0) 5 (18) 0 (0.0) Caftazidime 45 (9.8) 2 (4.1) 18 (7.8) 0 (0.0) 7 (5.8) 5 (4.8) 8 (5.0) 1 (4.8) 1 (3.3) 0 (0.0) 3 (11) 0 (0.0) Penicillins Ampicillin 412 (89) 35 (71) 215 (93) 11 (79) 68 (56) 59 (56) 18 (11) 3 (14) 12 (40) 6 (40) 21 (75) 8 (73) Quinolones Nalidixic acid 383 (83) 37 (76) 167 (73) 13 (93) 94 (78) 89 (85) 17 (11) 1 (4.8) 11 (37) 7 (47) 3 (11) 1 (9.1) Ciprofloxacin 56 (12) 5 (10) 27 (12) 1 (7.1) 7 (5.8) 7 (6.7) 8 (5.0) 0 (0.0) 1 (3.3) 3 (20) 1 (3.6) 0 (0.0) Tetracyclines Tetracycline 402 (87) 34 (69) 214 (93) 13 (93) 32 (26) 28 (27) 22 (14) 1 (4.8) 21 (70) 8 (53) 25 (89) 8 (73) Amphenicols Chloramphenicol 335 (73) 28 (57) 154 (67) 9 (64) 5 (4.1) 5 (4.8) 8 (5.0) 2 (9.5) 9 (30) 6 (40) 4 (14) 1 (9.1) Sulfonamides Sulfamethoxazole 398 (86) 35 (71) 206 (89) 12 (86) 60 (50) 53 (50) 31 (19) 3 (14) 15 (50) 7 (47) 21 (75) 5 (46) Trimethoprim 298 (65) 27 (55) 117 (51) 8 (57) 16 (13) 10 (9.5) 10 (6.3) 2 (9.5) 8 (27) 6 (40) 24 (86) 9 (82) Multi-resistance ≥3 antimicrobials 356 (77) 31 (63) 188 (81) 9 (64) 65 (54) 73 (70) 49 (31) 7 (33) 15 (50) 6 (40) 22 (79) 8 (73) ACSSuT* 244 (53) 25 (51) 92 (40) 6 (43) 3 (2.5) 3 (2.9) 2 (1.3) 1 (4.8) 6 (20) 4 (27) 3 (11) 1 (9.1)
Aminoglycosides Getamicin 3 (23) 1 (4.2) 2 (10) 2 (29) 2 (10) 1 (25) 3 (27) 1 (11) 4 (29) 1 (17) 37 (17) 19 (16) Streptomycin 3 (23) 3 (12) 2 (10) 2 (29) 12 (63) 3 (75) 3 (27) 3 (33) 4 (29) 2 (33) 61 (28) 37 (32) Cephalosporins Cefepime 3 (23) 1 (4.2) 2 (10) 2 (29) 1 (5.3) 1 (25) 4 (36) 1 (11) 3 (21) 1 (17) 20 (9.0) 19 (16) Cefotaxime 2 (15) 0 (0.0) 3 (15) 0 (0.0) 5 (26) 1 (25) 4 (36) 0 (0.0) 2 (14) 0 (0.0) 0 (0.0) 9 (7.7) Caftazidime 2 (15) 0 (0.0) 2 (10) 0 (0.0) 6 (32) 1 (25) 3 (27) 0 (0.0) 2 (14) 1 (17) 16 (7.2) 7 (6.0) Penicillins Ampicillin 1 (7.7) 2 (8.3) 16 (80) 6 (86) 12 (63) 1 (25) 11 (100) 9 (100) 3 (21) 2 (33) 79 (36) 33 (28) Quinolones Nalidixic acid 2 (15) 2 (8.3) 16 (80) 5 (71) 5 (26) 2 (50) 9 (82) 9 (100) 4 (29) 0 (0.0) 71 (32) 36 (31) Ciprofloxacin 0 (0.0) 1 (4.2) 0 (0.0) 0 (0.0) 0 (0.0) 2 (50) 1 (9.1) 0 (0.0) 3 (21) 1 (17) 19 (8.6) 4 (3.4) Tetracyclines Tetracycline 2 (15) 4 (17) 11 (55) 6 (86) 13 (68) 2 (50) 9 (82) 9 (100) 6 (43) 2 (33) 82 (37) 52 (44) Amphenicols Chloramphenicol 0 (0.0) 2 (8.3) 12 (60) 6 (86) 7 (37) 2 (50) 9 (82) 9 (100) 3 (21) 2 (33) 45 (20) 16 (14) Sulfonamides Sulfamethoxazole 3 (23) 5 (21) 15 (75) 6 (86) 14 (74) 2 (50) 10 (91) 9 (100) 3 (21) 1 (17) 79 (36) 50 (43) Trimethoprim 1 (7.7) 3 (12) 13 (65) 4 (57) 8 (42) 2 (50) 9 (82) 9 (100) 2 (14) 1 (17) 51 (23) 37 (32) Multi-resistance ≥3 antimicrobials 4 (31) 12 (50) 13 (65) 3 (43) 16 (84) 4 (100) 9 (82) 8 (89) 5 (36) 4 (67) 106 (48) 62 (53) ACSSuT* 0 (0.0) 0 (0.0) 1 (5.0) 2 (29) 6 (32) 1 (25) 3 (27) 3 (33) 1 (7.1) 1 (17) 25 (11) 12 (10)
Resistance to cefepime, cefotaxime, and ceftazidime was found in 10%, 11%, and 7.4% of isolates, respectively. Resistance to all three cephalosporin antimicrobials was seen in 99 isolates, of which patients <5 years accounted for 90% (89/99) and
A high prevalence of nalidixic acid resistance was observed (58%; 1,062/1,826) in the NTS isolates. A total of 155 isolates (8.5%, 155/1826) were resistant to ciprofloxacin. The overall resistance rate to ciprofloxacin increased from 2.4% in 2009 to 12% in 2012 (Figure
A rate of 63% (1156/1826) MDR was observed in NTS isolates in this study, with
In this study, we report epidemiologic characteristics of NTS infections in Guangdong Province from 2009 to 2012. An increase in the NTS isolation rate was observed beginning at 3.4% in 2009, 3.5% in 2010, 4.4% in 2011 and 5.1% in 2012. Since the surveillance was conducted, several training courses were designed by GDCDC for clinicians and lab staff to improve the capacity of detecting and reporting food-borne disease cases in Guangdong Province [
Our study showed that children aged <5 years were the group most affected by NTS in Guangdong Province. In a previous study, children <5 years were shown to be at risk for NTS infections [
Increasing antimicrobial resistance was observed in this study, especially to the conventional first-line agents, such as β-lactam antibiotics and quinolones. Regionally, NTS isolates recovered in Malaysia also showed high resistance rates to tetracycline (70%), sulfonamides (57%), and streptomycin (53%) but lower rates to ampicillin (30%),nalidicix acid (28%) and chloramphenicol (21%) than in China [
Extended-spectrum cephalosporins and fluoroquinolones have been recommended for treatment of diarrhea resulting from a NTS infection [
Reduced susceptibility to ciprofloxacin is a current trend in NTS isolates globally. The MIC of NTS isolates from Asian countries rose from 0.125 to 1 μg/ml during 2003 to 2005 [
This study had some limitations. First, selection of the sentinel hospitals was based on convenience but not the catchment size of the local population. Ten of the 28 hospitals involved were located in the capital city, Guangzhou, while only two or three hospitals included from the other cities in Guangdong. Future expansion of NTS surveillance in Guangdong should incorporate hospitals based on the coverage of the population in each catchment area. Second, only a minority of all patients with diarrhea have stool specimens collected for culture, as stool culture is not required in China for diarrheal patients. Finally, the
In conclusion,
It was a limitation that this study only included isolates from stool but not from blood and etc. Due to the statistic we have collected, we only can provide clinical correlates with these isolates about whether the cases are outpatients or inpatients. Since Fluoroquinolones are commonly used to treat serious diarrheal for adults while cephalosporins are often employed for children in China, we compared the resistance of cefepime, nalidixic acid, ciprofloxacin in inpatient cases is more severe than in outpatient cases (P < 0.01), respectively. If we assumed inpatient cases are more severe than outpatient cases, it seems like the high antibiotic resistance prevalence is associated with serious clinical diseases. However, more information should be collected and analyzed in the future.
Written informed consent was obtained from the patient’s guardian/parent/next of kin for the publication of this report and any accompanying images.
Non-typhoidalSalmonella
Guangdong center for disease control and prevention
Antimicrobial susceptibility testing
Clinical and laboratory standards institute
Multi-drug resistance
Resistance to ampicillin, chloramphenicol, streptomycin, sulfamethoxazole, tetracycline
The authors declare that they have no competing interests.
ZL carried out the
This study was supported by the China-U.
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.